FdaApplication
BLA 761109
Identifiers
- fda_app_no: BLA761109
Properties
| Property | Value |
|---|---|
| applicant_name | Eli Lilly and Company |
| application_type | BLA |
| approval_date | 2020-06-15 |
Products (6)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| LYUMJEV | INSULIN LISPRO-AABC | 300UNITS/3ML (100UNITS/ML) | Injection |
| LYUMJEV | INSULIN LISPRO-AABC | 1,000UNITS/10ML (100UNITS/ML) | Injection |
| LYUMJEV | — | 600UNITS/3ML (200UNITS/ML) | Injection |
| LYUMJEV | — | 300UNITS/3ML (100UNITS/ML) | Injection |
| LYUMJEV | — | 300UNITS/3ML (100UNITS/ML) | Injection |
| LYUMJEV | — | 300UNITS/3ML (100UNITS/ML) | Injection |
6 products